Simplifying Global Compliance
Court Rejects AbbVie Patent Suits, Boosting FTC Pay-for-Delay Claims
A federal judge in Pennsylvania threw out AbbVie’s patent suits against generic competitors, strengthening the Federal Trade Commission’s pay-for-delay case against the drugmaker.
To View This Article:
Subscribe To Generic Line
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing